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ABSTRACT
Introduction. The objective of this study was to evaluate the effect of 
ultrasound frequency and treatment duration on antibiotic-impreg-
nated polymethylmethacrylate (PMMA) antibiotic elution rates and 
mechanical strength.
Methods.xTwo batches of PMMA were prepared: one with five grams 
of vancomycin powder and one without. Each batch was divided 
into two frequency groups: kHz and MHz. Each frequency group 
was divided into two duration groups: two minutes and ten minutes. 
Elution samples were measured daily using flow injection analysis. 
After one week of elution, ultrasound treatments were done daily until 
each group’s average concentration fell below those of non-ultrasound 
control groups. After elution testing, compression testing determined 
mechanical properties. Paired t-tests were used to compare daily 
elution amounts to baseline values. Univariate ANOVAs were used to 
test for effects of both frequency and treatment duration on antibiotic 
elution amounts and on mechanical properties.
Results. All ultrasound treatments resulted in significant increases 
in antibiotic elution. Frequency and duration had significant effects of 
increasing antibiotic elution (p < 0.001). The kHz group produced sig-
nificantly greater antibiotic elution than the MHz group (p < 0.001). 
The 10-minute duration produced significantly greater antibiotic 
elution than the two-minute duration (both p < 0.001). Frequency 
and duration did not have significant effects on yield stress (p = 0.841 
and p = 0.179, respectively). Frequency had a significant effect (p = 
0.024) on modulus, but duration did not (p = 0.136).
Conclusions. Ultrasound frequency and treatment duration signifi-
cantly affect antibiotic elution from PMMA which may be helpful for 
treatment of periprosthetic joint infections during revision arthro-
plasty. Kans J Med 2019;12(2):45-49.
INTRODUCTION
Periprosthetic joint infection (PJI) is a devastating condition that 
can lead to significant patient morbidity. Infection rates for primary 
total knees and hips range from 0.3% - 3%.1-3 Infection rates follow-
ing revision due to infection were greater than primary rates from 5% 
- 10% despite aggressive debridement strategies and systemic antibi-
otic use.4-6 Two-stage revision is considered the standard method for 
treatment of chronic PJIs.7 As part of this strategy, antibiotic-loaded 
polymethylmethacrylate (PMMA) bone cement is used to maintain 
the space of the removed implants and to provide high concentra-
tions of antibiotic delivery needed to eradicate and inhibit biofilm 
formation.8,9 This technique allows for increased local antibiotic 
concentrations that would otherwise not be tolerated if delivered sys-
temically.10 The antibiotic elution duration profile typically is biphasic 
with a majority of the net total elution occurring within the first 
few days.11 The secondary, long-term phase may see concentration 
levels fall below critical physiological thresholds, such as minimum 
inhibitory concentrations (MIC) or minimum biofilm eradication 
concentration (MBEC), to provide adequate therapeutic effects.8,12,13 
Unfortunately, as much as 78% - 85% of the antibiotic can remain 
entrapped within the cement even after months of elution.14,15
Many factors can affect antibiotic release from bone cement. Anti-
biotic release is dependent on type of cement, antibiotic selection, 
preparation technique, and surface properties.11,16-18 Methods have 
been investigated to increase the permeability of cement so as to 
increase antibiotic elution and reduce antibiotic entrapment. Such 
techniques include the addition of antibiotic-loaded microspheres, 
poragens, modified mixing techniques, and use of ultrasound (US) 
exposure.19-22 Several techniques, however, produce undesirable side-
effects on the mechanical integrity of the cement and few have yet to 
be accepted and utilized widely by surgeons.23-25
US is effective in increasing antibiotic elution from standard bone 
cement.22,26-28 There remains, however, limited understanding of how 
sensitive elution rates are to varied US parameters and techniques. 
In particular, no study to date has shown the effect of clinically-rele-
vant US frequencies and treatment durations on long-term antibiotic 
elution from bone cement. While studies have demonstrated increased 
antibiotic elution over short periods, few have evaluated elution fol-
lowing US treatment for more than one week,17,29 which is far less than 
the length of time antibiotic spacers typically remain implanted in the 
body.30-32
The goal of this study was to use clinical US devices to determine 
if a higher or lower frequency would yield greater increases in antibi-
otic elution and to compare the effect of both shorter and longer daily 
treatment durations. The primary hypothesis was that US frequency 
and treatment duration have significant effects on antibiotic elution 
rates. It was hypothesized that US treatment in the kHz range would 
yield significantly greater antibiotic elution compared to the MHz 
range. Additionally, longer treatment durations would yield signifi-
cantly greater total antibiotic elution. Finally, both frequencies at 
either treatment duration would not have a significant effect on the 
mechanical integrity of the cement.
METHODS
The specimen preparation techniques used in this study followed 
previously established methods used by our lab for antibiotic elution 
study.20,26 For the current study, two 40 g batches of SmartSet MV 
(DePuy, Blackpool, United Kingdom) PMMA cement were prepared: 
one with five grams (12.5% by weight) of vancomycin powder (Sagent 
Pharmaceuticals Inc., Schaumburg, Illinois) added using a standard 
mixing technique and one without antibiotic to serve as a control. 
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Both preparations were made with a SmartMix cement mixing 
system (DePuy, Blackpool, United Kingdom) using a one Hz stir rate 
and a 30 kPa vacuum to remove air bubbles. Forty specimens were 
molded from each batch in accordance with ASTM standard F451-99a 
specifications.33 All specimens were cured for one hour in the molds 
before being removed, individually massed, and visually inspected for 
defects. Thirty specimens from the antibiotic group and thirty speci-
mens from the control group were placed in individual 50 mL vials 
with 10 mL of phosphate buffered saline (PBS) and stored in a 37° C 
incubator.
Twenty specimens of both batches were divided into two US fre-
quency ranges (kHz and MHz) and two treatment duration groups 
(two minutes and ten minutes) with five specimens in each group. The 
remaining ten specimens from the vancomycin batch received no US 
treatment for the duration of the study and provided baseline elution 
control values. The kHz frequency group was treated using a com-
mercial therapeutic cavitation US machine which operates at 40 kHz 
(Dia Panda Box, China). The MHz frequency group was treated using 
a Chattanooga Intellect clinical muscle therapy US machine set to run 
at 1 MHz (DJO, Guildford, United Kingdom). The output intensities 
of both machines were set to approximately 3 W/cm2. For each US 
treatment, the transducer of the US machine was placed vertically in 
a clamp and then each specimen’s vial was inverted and placed on top 
of the transducer head separated by a thin layer of US gel as shown in 
Figure 1.
Figure 1. A cement sample is shown undergoing ultrasound (US) treatment. 
The specimen is kept in its vile and placed directly on the transducer head with 
a thin layer of US gel.
US treatments were started after one week of standard elution 
and were done immediately following each day’s solution replace-
ment. Elution samples for concentration determination were taken 
just prior to each day’s solution replacement.
Daily antibiotic elution concentrations were determined using 
a previously described and validated flow injection analysis (FIA) 
technique.26 Specimens made from the cement batch having no van-
comycin were used to control for the presence of all solutes other 
than vancomycin. To do this, daily baseline FIA values of the non-
antibiotic loaded groups were subtracted from the FIA of their 
corresponding frequency and treatment duration antibiotic loaded 
groups. US treatments were run daily on each group until its daily 
average vancomycin concentration fell to within 160% of the average 
value for the non-US group on that same day. Analysis was done using 
Matlab (The MathWorks, Natick, MA, USA) and Excel (Microsoft 
Corporation, Redmond, WA, USA) software.
All specimens were tested mechanically in compression once each 
group’s US treatment period was concluded. Compression testing 
was done in accordance with ASTM F451-99a to evaluate offset yield 
stress and elastic modulus.33 Testing was done with a MTS 858 Mini 
Bionix II hydraulic load frame (MTS Systems, Eden Prairie, Min-
nesota). Offset yield stress results were compared to the minimum 
strength threshold defined by International Standards Organization 
(ISO) 5833:2002.34 Mechanical analysis also was done using Matlab 
and Excel software.
For total elution, univariate ANOVAs were used to test for signifi-
cant effects of frequency and treatment time on average total elution 
increases. Post-hoc paired t-tests were used to compare net total 
elution amount averages of the four treatment groups. For mechani-
cal properties, univariate ANOVAs were used to test for effects of 
frequency, treatment duration, and addition of antibiotic on offset 
yield stress and elastic modulus. Post-hoc paired t-tests were used to 
compare individual groups. Statistical analysis was calculated using 
Excel and SPSS (IBM Corporation, Armonk, NY, USA) software.
RESULTS
Average daily antibiotic elution concentrations for each group are 
shown in Figure 2.
All US treatment groups produced increased antibiotic elution 
significantly above the non-US group on the first day of US treat-
ment. The kHz frequency group produced the longest sustained 
increases in elution to nine and 16 days after the start of US treatment 
for two and 10 minute treatment times, respectively. The MHz group 
sustained increases to six and five days after the start of US treatment 
for two and 10 minute treatment times, respectively. 
The average net sum of increased antibiotic elution above non-US 
elution for each group is shown in Figure 3. This represents the 
amount of additional antibiotic that can be attributed to the US treat-
ment over the course of the study.
US frequency and treatment duration each had significant uni-
variate effects on increasing antibiotic elution (p < 0.001). The kHz 
groups each produced significantly greater antibiotic elution than the 
MHz groups (p < 0.001). The 10-minute duration groups produced 
significantly greater antibiotic elution than the two-minute duration 
groups (both p < 0.001).
Results from the mechanical testing are shown in Figure 4. The 
addition of the antibiotic to the cement had a significant univari-
ate effect of reducing both offset yield stress and elastic modulus (p 
< 0.001). For offset yield stress, both US frequency and treatment 
duration did not have significant univariate effects (p = 0.841 and 
p = 0.179, respectively). For elastic modulus, US frequency had a 
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significant univariate effect (p = 0.024), but treatment duration did 
not (p = 0.136). All groups maintained offset yield stresses significant-
ly above the 70 MPa limit specified by ISO 5833:2002 (p < 0.001).34
Figure 2. Comparison of daily average elution amounts for non-ultrasound 
(US) controls and all treatment groups. The top figure shows the entire 
non-US group elution profile and the US treatment groups for their respective 
treatment durations. The bottom figure shows both non-US and treatment 
groups but for only the US treatment period which began on day seven. Error 
bars in the lower plot indicate ± one standard deviation.
Figure 3. Average net sum of the increased vancomycin elution above non-
ultrasound (US) elution for combinations of US frequencies and treatment 
durations. Error bars indicate ± one standard deviation.
DISCUSSION
Our baseline vancomycin elution rates were in agreement with 
previously reported values from studies that utilized similar meth-
odology20,26 and exhibited elution curves which closely match 
relative profiles observed in-vivo.35,36 Both US frequency and 
treatment duration time had significant effects on increasing anti-
biotic elution. The kHz frequency at the longer duration produced 
both the greatest significant increase in total amount and the 
        ULTRASOUND FREQUENCY ON ANTIBIOTIC   
        ELUTION 
            continued.
Figure 4. Average values are shown for offset yield stress (top) and elastic 
modulus (bottom) for no-antibiotic and vancomycin-loaded cement samples 
at the end of each test group’s elution period. Error bars indicate ± one stan-
dard deviation.
longest-sustained increase in antibiotic elution. The MHz frequency 
at both durations produced significant increases in elution, however, 
at lesser amounts than the kHz groups and for fewer days. This was 
to be expected as higher frequencies are known to see greater atten-
uation, particularly in more dense materials like bone cement and 
bone.37 
The number of days that US significantly increased antibiotic 
elution ranged from five to 16. This is similar to the typical length of 
the primary elution phase which is usually around one week. Given 
that a six week (42 day) treatment period commonly is used for two-
stage revision arthroplasty,7 the addition of US treatment improves 
current treatment from around a quarter to roughly half of the 
typical treatment period. While our study design was such that we 
were unable to run statistical comparisons based on number of days 
of significant increases, the results indicated that US treatment may 
provide a meaningful improvement in the amount of time that the 
spacer can be used to deliver adequate antibiotic concentrations.
Given that both bone and PMMA cement have relatively high 
acoustic impedances and quickly dampen the propagation of US 
waves,37 the greatest opportunities for increasing antibiotic elution 
from spacers with US likely exist at the perimeter of the joint space. 
The most immediately exposed surfaces would include molded spacer 
surface edges and any exposed backing cement used to anchor the 
spacers in place. The surface area of the ASTM F451-99a specimens 
represents only a small fraction of the total surface area of a spacer, 
likely multiple orders of magnitude smaller. With this in mind, it 
seems likely that truly meaningful amounts of increased antibiotic 
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elution could be achieved with US treatment. Further investigations 
are needed to determine what the true US wave propagation and 
attenuation would be in-vivo and what amount of surface area can 
effectively be treated to produce increased antibiotic elution.
A key factor in the use of US for long-term antibiotic elution modu-
lation is the relation of elution levels to clinically-based targets such 
as MIC or MBEC for specific PJIs. In the present study design, the 
resulting concentrations are highly dependent on independent study 
parameters including specimen size, PBS storage volume, and amount 
of antibiotic used. Ultimately, additional biological factors such as 
patient body habitus, medical comorbidities, and types of organisms 
involved would need to be considered along with joint space volumes 
and anticipated elution rates to determine the effectiveness of a par-
ticular US treatment strategy.
There is a wide variety of antibiotic treatment durations that are 
considered adequate or necessary for treatment of PJIs.7,38 Given 
the high amounts of antibiotic that remain entrapped within the 
cement,14,15 there is also a question of whether an antibiotic’s effec-
tiveness degrades over time or if its stability is preserved so that its 
release might be useful. Future investigations are needed to determine 
if entrapped antibiotics can be utilized for long term PJI treatment.
The mechanical compression test results showed no significant 
effect of either frequency or treatment duration on offset yield stress 
and that, as a previous study has shown, the addition of the antibiotic 
has a greater impact on mechanical properties than treatment with 
US.26 Although there was a significant univariate effect of frequency 
on elastic modulus, the effect seems small and of less concern clini-
cally compared to the decrease in modulus caused by the addition of 
the antibiotic itself. The increased total antibiotic elution of the kHz 
group compared to the MHz group may explain the decrease in elastic 
modulus. It may be possible that greater total elution of antibiotic 
results in greater mass loss for the bulk material, which in turn results 
in decreased stiffness. This may, however, be difficult to prove in the 
presence of ongoing polymerization.39
An important aspect to consider is the effect of US treatment on 
the tissues exposed to US and the physiological responses. Both US 
devices used in the study were designed primarily for therapeutic 
effects on subdermal tissues. The overall treatment effectiveness tar-
geting antibiotic loaded cement would need to be balanced with an 
understanding of the secondary effects on the surrounding tissues. 
In the case of joint arthroplasty, the secondary effects may provide 
beneficial improvements in osteogenesis, local blood flow, pharma-
cokinetics, and adjacent tissue healing, however, additional studies 
would be necessary to prove the efficacy of such responses.40-42 
Both frequency and power are relevant US parameters that contrib-
ute to the effectiveness of US as a technique for elution modulation. 
In this study, the use of two different clinical machines meant that, 
although we attempted to keep the applied intensity consistent, all 
factors were not controlled for that may have been different between 
them. Nevertheless, the strategy for the present study was to normal-
ize the effect of US power differences by setting each machine to a 
similar output intensity and by placing the specimens at equal relative 
position and distance from each machine’s transducer. Such tech-
niques have been utilized in similar studies evaluating effects of US 
on elution.21,22 While more sophisticated laboratory US equipment 
could be used to compare more precisely specific frequencies, most 
clinical US machines provide only limited control over power adjust-
ments and it was important to utilize machines more likely to be used 
in a clinical setting.
When considering US treatment as part of a larger strategy for 
increasing long-term antibiotic elution, combination with other 
elution augmentation techniques like modified mixing techniques 
and the use of additives may have symbiotic effects.26,43 The use of US 
exposure along with incorporation of resorbable filler materials such 
as poragens or other antibiotics may simultaneously increase filler 
resorption and antibiotic release.24,43 Further study is needed to deter-
mine whether combined modulation techniques provide additional 
benefits beyond simply the sum of individual techniques.
In addition to the previously discussed limitations of a basic in-
vitro environment with limited physiological relation to the true 
in-vivo environment, only a single antibiotic was tested, and only at a 
single dosage amount. In the clinical setting, a wide variety of antibiot-
ics are used with dosages chosen based on a variety of patient-specific 
factors. Future investigations would be required to determine the 
effects of US frequency and treatment durations for these particular 
instances. An additional limitation is that only a single specimen size 
was used. Although ASTM F451-99a is one of the most commonly 
utilized standards for antibiotic elution studies, its original intent 
was specifically for mechanical evaluation of cement, and as such, is 
not optimized for evaluation of elution. Future work should expand 
beyond this methodology to include environmental and physiologi-
cal factors that better represent the in-vivo condition and provide 
improved clinical relevance.
CONCLUSION
Lower (kHz range) frequency US was able to sustain an increased 
antibiotic elution rate compared to higher (MHz range) frequen-
cies at similar treatment durations. Sustained increases in antibiotic 
elution were achieved ranging from less than a week to more than two 
weeks. The effect of US treatment on mechanical properties were 
minimal and the addition of the antibiotic played the biggest role in 
reducing offset yield strength and stiffness. The results of this study 
indicated that varying US frequency and treatment durations allows 
for elution modulation such that strategies could be devised to achieve 
either longer-sustained releases at lower amounts or higher releases 
over shorter periods. Such strategies could allow for improved control 
and management of PJIs.
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